These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 8761480

  • 1. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
    O'Connell JC, McCallum JF, McPhee I, Wakefield J, Houslay ES, Wishart W, Bolger G, Frame M, Houslay MD.
    Biochem J; 1996 Aug 15; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
    [Abstract] [Full Text] [Related]

  • 2. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I, Pooley L, Lobban M, Bolger G, Houslay MD.
    Biochem J; 1995 Sep 15; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [Abstract] [Full Text] [Related]

  • 3. In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting.
    Beard MB, Huston E, Campbell L, Gall I, McPhee I, Yarwood S, Scotland G, Houslay MD.
    Cell Signal; 2002 May 15; 14(5):453-65. PubMed ID: 11882390
    [Abstract] [Full Text] [Related]

  • 4. Association with the SRC family tyrosyl kinase LYN triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B. Consequences for rolipram inhibition.
    McPhee I, Yarwood SJ, Scotland G, Huston E, Beard MB, Ross AH, Houslay ES, Houslay MD.
    J Biol Chem; 1999 Apr 23; 274(17):11796-810. PubMed ID: 10206997
    [Abstract] [Full Text] [Related]

  • 5. The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains.
    Beard MB, O'Connell JC, Bolger GB, Houslay MD.
    FEBS Lett; 1999 Oct 22; 460(1):173-7. PubMed ID: 10571082
    [Abstract] [Full Text] [Related]

  • 6. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution.
    Huston E, Beard M, McCallum F, Pyne NJ, Vandenabeele P, Scotland G, Houslay MD.
    J Biol Chem; 2000 Sep 08; 275(36):28063-74. PubMed ID: 10829034
    [Abstract] [Full Text] [Related]

  • 7. Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines.
    Pooley L, Shakur Y, Rena G, Houslay MD.
    Biochem J; 1997 Jan 01; 321 ( Pt 1)(Pt 1):177-85. PubMed ID: 9003417
    [Abstract] [Full Text] [Related]

  • 8. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M, Rohner D, Bichsel S.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):729-34. PubMed ID: 8607833
    [Abstract] [Full Text] [Related]

  • 9. Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVA1) can confer membrane association upon the normally cytosolic protein chloramphenicol acetyltransferase.
    Scotland G, Houslay MD.
    Biochem J; 1995 Jun 01; 308 ( Pt 2)(Pt 2):673-81. PubMed ID: 7772057
    [Abstract] [Full Text] [Related]

  • 10. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S, Houslay MD.
    Biochem J; 1997 Jan 01; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [Abstract] [Full Text] [Related]

  • 11. Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.
    Houslay MD, Scotland G, Erdogan S, Huston E, Mackenzie S, McCallum JF, McPhee I, Pooley L, Rena G, Ross A, Beard M, Peder A, Begg F, Wilkinson I, Yarwood S, Ackerman C, Houslay ES, Hoffman R, Engels P, Sullivan M, Bolger G.
    Biochem Soc Trans; 1997 May 01; 25(2):374-81. PubMed ID: 9191121
    [No Abstract] [Full Text] [Related]

  • 12. Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions.
    Lobban M, Shakur Y, Beattie J, Houslay MD.
    Biochem J; 1994 Dec 01; 304 ( Pt 2)(Pt 2):399-406. PubMed ID: 7998974
    [Abstract] [Full Text] [Related]

  • 13. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T, Sakai R, Ozawa K, Yazaki Y, Hirai H.
    J Biol Chem; 1996 Apr 12; 271(15):8959-65. PubMed ID: 8621540
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.
    Shakur Y, Wilson M, Pooley L, Lobban M, Griffiths SL, Campbell AM, Beattie J, Daly C, Houslay MD.
    Biochem J; 1995 Mar 15; 306 ( Pt 3)(Pt 3):801-9. PubMed ID: 7702577
    [Abstract] [Full Text] [Related]

  • 15. Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10.
    Rena G, Begg F, Ross A, MacKenzie C, McPhee I, Campbell L, Huston E, Sullivan M, Houslay MD.
    Mol Pharmacol; 2001 May 15; 59(5):996-1011. PubMed ID: 11306681
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
    Solomaha E, Szeto FL, Yousef MA, Palfrey HC.
    J Biol Chem; 2005 Jun 17; 280(24):23147-56. PubMed ID: 15834155
    [Abstract] [Full Text] [Related]

  • 17. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
    Hunter S, Burton EA, Wu SC, Anderson SM.
    J Biol Chem; 1999 Jan 22; 274(4):2097-106. PubMed ID: 9890970
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2.
    Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS, Houslay MD.
    J Biol Chem; 2003 Aug 29; 278(35):33351-63. PubMed ID: 12810716
    [Abstract] [Full Text] [Related]

  • 19. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.
    Weng Z, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Dreyfuss G, Brugge JS.
    Mol Cell Biol; 1994 Jul 29; 14(7):4509-21. PubMed ID: 7516469
    [Abstract] [Full Text] [Related]

  • 20. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R, Komas N, Ekholm D, Murata T, Taira M, Hockman S, Degerman E, Manganiello VC.
    Cell Biochem Biophys; 1998 Jul 29; 29(1-2):89-111. PubMed ID: 9631240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.